ADMA Stock Summary and Trading Ideas (Adma Biologics | NASDAQ:ADMA)

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

Adma Biologics trades on the NASDAQ stock market under the symbol ADMA.

As of January 15, 2025, ADMA stock price climbed to $17.11 with 571,546 million shares trading.

ADMA has a beta of 1.96, meaning it tends to be more sensitive to market movements. ADMA has a correlation of 0.14 to the broad based SPY ETF.

ADMA has a market cap of $4.04 billion. This is considered a Mid Cap stock.

Last quarter Adma Biologics reported $120 million in Revenue and $.15 earnings per share. This beat revenue expectation by $14 million and exceeded earnings estimates by $.02.

In the last 3 years, ADMA traded as high as $23.64 and as low as $1.30.

The top ETF exchange traded funds that ADMA belongs to (by Net Assets): IJR, VTI, IWM, XBI, VXF.

ADMA has outperformed the market in the last year with a return of +242.9%, while the SPY ETF gained +25.7%. In the last 3 month period, ADMA beat the market returning +4.5%, while SPY returned +1.7%. However, in the most recent 2 weeks ADMA has underperformed the stock market by returning -0.2%, while SPY returned +1.0%.

ADMA support price is $15.77 and resistance is $16.87 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ADMA shares will trade within this expected range on the day.